Danaher Corp., US2358511028

Danaher Corp. stock pre-market at EUR 197.68: laboratory tools group

Published on 10/21/2026 at 08:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danaher operates in biotechnology, diagnostics and life sciences. At Lang & Schwarz the stock trades pre-market at EUR 197.68 on October 21, 2026.

Business model and reporting agenda

  • Its operations span biotechnology, diagnostics and life sciences.
  • Danaher was scheduled to report third-quarter results before the U.S. market opened on October 21, 2026.
  • Danaher Corp. stock trades pre-market at EUR 197.68 at 8:08 a.m. CEST at Lang & Schwarz on October 21, 2026.
Danaher Corp. moderner Life-Sciences-Campus US2358511028 als photorealistischer Architektur-Render bei warmem goldenen Abendlicht, Illustration mit AI erstellt.

Danaher develops tools, software, technologies and services across biotechnology, diagnostics and life sciences, according to its corporate website. At Lang & Schwarz, Danaher Corp. stock trades pre-market at EUR 197.68 at 8:08 a.m. CEST on October 21, 2026.

Ahead of the Xetra open

The pre-market indication comes before the 9:00 a.m. CEST Xetra open. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Danaher Corp. stock.

The group and its market

Danaher earns revenue through businesses serving biotechnology, diagnostics and life sciences, including tools, software, technologies and services for customers in healthcare and scientific research. A Reuters report published by Investing.com on October 20, 2026 said Danaher was scheduled to report third-quarter results before the U.S. market opened on October 21, 2026; Reuters via Investing.com reported that analysts were focused on bioprocessing recovery and the first earnings call of CEO Julie Sawyer Montgomery.

Market context: Latest market reports.

More news and analysis on Danaher Corp. stock

Disclaimer...
en | US2358511028 | DANAHER CORP. | boerse | 70379791 | bgmi